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Abstract
When modelling HIV epidemics, it is important to incorporate set-
point viral load and its heritability. As set-point viral load distributions
can differ significantly amongst epidemics, it is imperative to account
for the observed local variation. This can be done by using a heri-
tability model and fitting it to a local set-point viral load distribution.
However, as the fitting procedure needs to take into account the ac-
tual transmission dynamics (i.e., social network, sexual behaviour), a
complex model is required. Furthermore, in order to use the estimates
in subsequent modelling analyses to inform prevention policies, it is
important to assess parameter robustness.
In order to fit set-point viral load models without the need to cap-
ture explicitly the transmission dynamics, we present a new protocol.
Firstly, we approximate the transmission network from a phylogeny
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that was inferred from sequences collected in the local epidemic. Sec-
ondly, as this transmission network only comprises a single instance of
the transmission network space, and our aim is to assess parameter ro-
bustness, we infer the transmission network distribution. Thirdly, we
fit the parameters of the selected set-point viral load model on multiple
samples from the transmission network distribution using approximate
Bayesian inference.
Our new protocol enables researchers to fit set-point viral load mod-
els in their local context, and diagnose the model parameter’s uncer-
tainty. Such parameter estimates are essential to enable subsequent
modelling analyses, and thus crucial to improve prevention policies.
1 Introduction
The human immunodeficiency virus (HIV) targets the immune system of the
host and eventually leads to acquired immunodeficiency syndrome. There
are two different types of HIV: HIV-1 and HIV-2. HIV-1 is divided into four
groups: M, N, O, P. HIV-1 group M is responsible for the current global
HIV epidemic, and has been subdivided into subtypes A, B, C, D, F, G, H,
J and K [12]. Different geographical regions are associated with particular
subtype distributions [16], as visualized in Figure 1.
In 2017, 36.9 million people worldwide were living with HIV-1 and 1.8
million new HIV infections occurred [1]. Although this number of new in-
fections per year is decreasing thanks to easier access to treatment, this
decrease is stagnating and HIV remains a great concern, due to scale-up of
antiretroviral treatment, especially in sub-Saharan Africa [23].
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Figure 1: Global map showing the spread of HIV subtypes per continent
(Wikipedia, derived from [16]).
In 2016, a total of 29444 new HIV diagnoses were reported by the 31
countries of the EU/EEA [2]. In Portugal, over 44 624 people are currently
living with HIV, according to the national report of 2017 [3].
HIV is no longer an untreatable condition and an HIV therapy consists of
administering a drug regimen, an highly active anti-retroviral therapy. HIV
is a rapidly replicating virus, because of this, HIV can become resistant to
the administered therapy. To mitigate the effects of HIV-1 drug resistance,
it is important to closely follow up treated patients.
In order to closely monitor the diseases progression of HIV-1 patients,
the viral load (i.e., the number of viral particles in the serum) needs to
be measured regularly. Closely related to this marker is the set-point viral
load, i.e., the viral load that is measured after the acute phase of the infec-
tion (see Figure 2). An individual’s set-point viral load is associated with
disease progression and transmissibility of the virus, as such, the distribu-
tion of the set-point viral loads in a population is an important determinant
of the transmission dynamics of the epidemic. Furthermore, as set-point
viral load is partly inherited by the infectee, this induces a complex inter-
play between intra-patient and inter-patient processes. Additionally, it has
been well studied that set-point viral load distributions can differ signifi-
cantly between different locations [7]. It is therefore important to consider
the population’s set-point viral load distribution to better understand the
characteristics of a particular HIV-1 epidemic.
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Figure 2: Plot of the average viral load function (red) and average CD4 cell
count (blue) of an untreated HIV patient. The set-point viral load is the
viral load that directly follows the acute phase, at around 12 weeks after
seroconversion. This figure was adapted from the figure presented in [20].
As such, when modelling HIV epidemics, it is important to incorporate
set-point viral load and its heritability [21]. As set-point viral load distribu-
tions can differ significantly amongst epidemics, it is imperative to account
for the observed local variation. This can be done by using a heritability
model and fitting it to a local set-point viral load distribution. However, as
the fitting procedure needs to take into account the actual transmission dy-
namics (i.e., social network, sexual behaviour), a complex model is required.
Furthermore, in order to use the estimates in subsequent modelling anal-
yses to inform prevention policies, it is important to assess the parameter
robustness.
2 Objectives
Our aim in this work is to provide a new protocol, to fit set-point viral load
models without the need to explicitly capture the transmission dynamics.
We will present the methodology for this new protocol and evaluate it in the
context of the Portuguese HIV-1 epidemic. The Portuguese HIV-1 epidemic
is unique, as it comprises two parallel epidemics, clearly distinguished by
their HIV-1 subtype, i.e., HIV-1 subtype B and HIV-1 subtype G [17].
Our new protocol will enable researchers to fit set-point viral load models
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in their local context (i.e., the specifics of the epidemic: virus’ evolutionary
rate, diagnosis rate, transmission route, ...), and diagnose the model param-
eter’s uncertainty (see Figure 8 and Figure 9). Such parameter estimates
are essential to enable subsequent modelling analyses and therefore crucial
to improve prevention policies.
3 Methods
In Figure 3, we give an overview of the procedure to infer the transmission
network distribution. In Figure 4, we illustrate how we infer the set-point
viral load (SPVL) transmission model.
First, we calculate the genetic distances between the patient’s genetic
virus sequences. This distance matrix, can be represented as a graph where
nodes represent patients and the edges between the nodes are weighted with
the genetic distance between the genetic virus sequences of these patients
(I). We then remove all edges from this graph where the distance exceeds a
specified threshold. This results in a network where every node is connected
to their potential transmission partners (II) [24]. We then infer the degree
distribution of the network of potential transmission partners (III). This
model is used to sample possible transmission networks of the transmission
network distribution (IV). We sample the network using Chung’s algorithm
[6].
From this sampled network of potential transmission partners, we obtain
a minimum spanning tree (V). We will use this spanning tree to model the
HIV transmission network. Every node in the graph represents a patient. In
this spanning tree, every edge represents an actual HIV transmission. We
then seed random nodes with a set-point viral load (VI, the infected node
is shown in red). Consequently, we use a model for transmitting set-point
viral load values to infect the neighbors of this node (VII). We propagate the
infection through the entire network until every node has been infected and
thus was assigned a set-point viral load value. We extract the distribution
of generated set-point viral loads from the network and compare this to
the empirical distribution estimated from the viral loads extracted from
the Portuguese HIV resistance database (VIII) [22]. We use Approximate
Bayesian Computation in combination with the previous steps to learn the
parameter distribution of the set-point viral load model.
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Figure 3: A visualization of the work flow of our protocol: computing the
pairwise genetic distances between viral isolates (I), removing all connections
whose distance is over a certain threshold (II), fitting a neighbor degree
distribution on this network (III) and then sampling a network from this
distribution (IV).
3.1 Transmission networks as graphs
The topology of a network of HIV-infected individuals is often visualized
as a phylogenetic tree. However, a phylogenetic tree depicts the distinct
viral lineages rather than the relation between an infector and an infectee
[24, 18]. We therefore represent transmission networks as graphs [24], where
every node represents a patient and every edge between nodes encodes that
those patients are possible transmission partners. An example of a graph is
given in Figure 5. For this example, the graph represents that patients A,
B and C were possibly infected by patient D. However, since transmission
networks are undirected graphs, there are multiple possible interpretations.
It could, for example, be possible that patient A was the one to infect patient
D, who then infected patients B and C.
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Figure 4: A visualization of the protocol work flow: sampling a spanning
tree from the network of potential transmission partners (V), seeding a ran-
dom node with a set-point viral load value (VI), propagating the infection
through the network (VII) and comparing the generated SPVL distribution
to the empirical SPVL distribution to obtain a quality measure of the model
parameters used for seeding and propagating the SPVLs (VIII).
Figure 5: An example HIV transmission network represented as an undi-
rected graph. The undirectedness means it is impossible to see whether
patient D has infected patient E or vice versa.
In order to approximate the transmission network, we use the distance
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matrix, where each entry (i, j) comprises the distance between the genetic
virus sequences of patient pi and pj . From this distance matrix, we create a
fully connected graph in which each node represents a patient and the edge
between every two nodes is the genetic distance between the patients’ virus
sequences (I in Figure 3). We then remove all edges with a weight exceeding
a specified threshold (II in Figure 3). Every edge now represents a possible
transmission. Subsequently, we compute a spanning tree from this network
to obtain a realistic HIV transmission network (III in Figure 3).
The simplest genetic distance is the pairwise distance measure, that cor-
responds to the proportion of changed nucleotide sites to the total number of
nucleotide sites [11]. However, the pairwise distance measure underestimates
the actual evolutionary distance, as differences at nucleotide sites might get
reverted during the evolutionary process, or we might miss evolutionary sig-
nal between the observed nucleotide sites (show in Figure 6). In order to
mitigate this bias, different nucleotide substitution models were developed.
In this work, we use the Tamura-Nei model [19], a substitution model that
allows for different nucleotide substitution rates, as this has previously been
shown adequate to infer transmission networks [24].
Figure 6: A plot of the true distance d versus the p-distance illustrates the
saturation of the distance measure for high divergence [11].
As this transmission network only comprises a single instance of the
transmission network space, and our aim is to assess the parameter’s ro-
bustness, we infer the transmission network distribution. We model this
using a Waring degree distribution Waring(x, ρ) or a Yule degree distribu-
tion Yule(x, ρ) [24], for which we need to estimate the ρ parameter based on
the transmission network that was inferred from the virus sequence data.
In [24], ρ was estimated on the complete set of sequences. We do how-
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ever make the observation that the genetic distance distribution of HIV-1
subtype B and HIV-1 subtype G sequences significantly differs, as is visual-
ized In Figure 7. In our experiments, we will therefore estimate a separate
distribution for the different subtypes.
Figure 7: The distance distribution of our data is shown per combination
of subtypes where we show the density of the distance distribution. It is
clear that the distance between patients with subtype G and patients with
subtype B is significantly larger than the distance between two patients with
the same subtype.
3.2 Models of HIV spread
Research has shown that the value of a patient’s set-point viral load is
partially caused by the genetic code of the virus and is thus partially trans-
mitted [9, 7, 5, 10]. To build a transmission network for investigating the
distribution of set-point viral loads that arise, two methods for establishing
a new set-point viral load must be applied. Firstly, a method for assigning
an SPVL to a patient zero in a network (we call this seeding):
P (spvl) (1)
Secondly, a method for calculating the SPVL of an infectee, given the SPVL
of the infector:
P (spvlinfectee |spvlinfector ) (2)
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The Simpact model 1 provides two models to determine new set-point
viral loads. The first model uses a two-dimensional probability density func-
tion to determine the probability of having a set-point viral load for every
viral load of the infectee and the infector. The second model uses a one-
dimensional probability density function to seed new viral loads and uses
the set-point viral load of the infector with noise for transmitted set-point
viral loads.
The first model uses a two-dimensional distribution to calculate the prob-
ability of an infected person (infectee) having a certain set-point viral load,
given the set-point viral load of the person that infects (infector). The
conditional probability function we are interested in is
P (spvlinfectee |spvlinfector ) (3)
which is implemented in this model as a joint probability function
P (spvlinfector , spvlinfectee) (4)
To seed a new set-point viral load without knowledge of the set-point
viral load of the infector, the marginal distribution is used:
P (spvlinfectee) =
∫
P (spvlinfector , spvlinfectee)dspvlinfectee (5)
The actual two-dimensional probability density function from the Sim-
pact study is defined by a bi-variate normal distribution with equal param-
eters. The standard case of a bi-variate normal distribution is defined by:
P (x, y) =
1
2piσ1σ2
√
1− ρ2 exp[−
z
2(1− ρ2) ] (6)
with
z ≡ (x− µ1)
2
σ21
− 2ρ(x− µ1)(y − µ2)
σ1σ2
+
(y − µ2)2
σ22
(7)
Since we are working with a symmetric version of this formula where σ1 = σ2
and µ1 = µ2, we can rewrite this formula as
P (x, y) =
1
2piσ2
√
1− ρ2 exp[−
z
2(1− ρ2) ] (8)
with
z ≡ (x− µ)
2 + (y − µ)2 − 2ρ(x− µ)(y − µ)
σ2
] (9)
1https://github.com/j0r1/simpactcyan
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In Simpact, the following parameters are proposed: µ = 4 , σ = 1 and
ρ = 0.33 as default values. This probability density function is limited on
both axes to the interval [log10 4 copies/ml, log10 8 copies/ml].
The second model seeds new set-point viral loads from a log-Weibull
distribution. The set-point viral load in this case is calculated by taking the
set-point viral load of the infector and adding Gaussian noise.
spvlinfectee = spvlinfector +N (µ = 0, σ2 = (θ ∗ spvlinfector )2) (10)
θ determines the standard deviation of the noise to a fraction of the set-
point viral load of the infector, it is 0.1 by default.
Since this addition of Gaussian noise can result in a negative set-point viral
load. We resolve this by re-sampling the noise from the last step until the
resulting set-point viral load is non-negative.
We propose a third way of modeling set-point viral load heritability, that
uses the underlying set-point viral load distribution directly and results in a
more intuitive and simpler model. The seeding of patients is not something
that has a biological equivalent. Clearly, individuals do not develop HIV on
their own without having had contact with another HIV-infected individual.
Seeding events are introduced to bootstrap our simulations. We therefore
believe that a plausible way of seeding an individual would be to sample a
new set-point viral load value from a log-normal SPVL model. This way,
seeding a new set-point viral load value is done by sampling one from the
distribution
spvlinfectee = LogNormal(µ, σ
2) (11)
Transmission of a set-point viral load in this model is done by adding
Gaussian noise to the set-point viral load of the infector:
spvlinfectee = spvlinfector +N (µ = 0, σ2) (12)
3.3 Exploring the SPVL model’s parameter distributions
For simulating local HIV transmission networks, like the ones found in Portu-
gal, the set-point viral load transmission models need to be parameterized.
More specifically, we are interested to learn the parameters’ distribution.
For this purpose, Markov chain Monte Carlo methods are often preferred.
However, such methods require that a likelihood function is available. In
the context of our set-point viral load models, such a likelihood function is
computationally intractable. We therefore will use Approximate Bayesian
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Computation (ABC), as this technique allows the use of Bayesian inference,
in a context where no likelihood function is available, but the output of a
model can be compared to data using some kind of distance function.
In this work, we will compare the empirical distribution to the generated
distribution using the Hellinger distance [8].
4 Experiments
In this experiment, we use data that describes the Portuguese HIV-1 epi-
demic, and was exported from the RegaDB instance from the Egas Moniz
hospital [13].
For our analyses, we require viral load samples and genetic sequences.
The viral load samples are used to approximate the set-point viral load dis-
tribution. The genetic sequences are used to infer the transmission network.
We use the polymerase genetic region of the HIV virus and more specifically
consider the protease and reverse transcriptase regions. The reason for this
is that these genetic regions are collected as standard patient care, as these
regions are also used to assess drug resistance in HIV patients. In order to
compute the distance matrix between the sequences, the sequences need to
be aligned, for which we used the VIRULIGN method that implements a
codon correct alignment procedure specifically tailored for virus sequences
[14]. As mentioned earlier, we observe that the genetic distance distribution
significantly differs between subtypes, therefore the sequence dataset was
split into three parts, subtype B (53% of the dataset), subtype G (31% of
the dataset) and others. For this analysis, we will only consider the subtype
B and subtype G datasets. The subtyping analysis was performed using the
REGA genotyping framework [4]. Note that in the context of transmission
networks, separating between subtypes is a natural thing to do, as epidemics
that are comprised of different subtypes are inherently separate.
From Figure 7, it is clear that the different subtypes require a custom
threshold. For subtype B, we use the threshold as used in [24], and for
subtype G we use the threshold that would yield the same percentile of the
distribution as potential transmission partners.
We experimented with three different models of set-point viral load her-
itability, as defined in the previous section: a symmetric bi-variate model, a
log-Weibull model with noise and a simple normal model. Furthermore, we
explored two degree distributions: a global network, a network of Portuguese
patients with subtype B (Waring distribution, ρ = 3.1) and a network of Por-
tuguese patients with subtype G (Yule distribution, ρ = 2.6). Additionally,
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we experimented with three different seeding proportions, corresponding to
0.27%, 0.56% and 0.83% of all nodes.
We ran every ABC experiment for 200000 iterations and discarded the
first 20000 ABC samples. An example result, from the log-Weibull model
with noise for subtype B with 0.28% seeded nodes, is shown in Figure 8,
which demonstrates interesting parameter distributions (i.e., distinct peaks
versus a more flat surface) that will be useful to inform prospective simu-
lations in a more complex individual-based model. Distinct peaks indicate
clear models with little uncertainty, while flat surfaces indicate that the
parameter might be less important, or that further analysis is warranted.
Another example result, from the log-Normal model for subtype B with
0.28% seeded nodes, is shown in Figure 9.
In future work, we plan to perform a detailed comparison between the
different set-point viral load models we described, using the methods pre-
sented in this work, in conjunction with a more complex individual-based
model.
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Figure 8: The posterior estimation of the parameters of the log-Weibull
with noise model for the network with subtype B (sampled from a Waring
distribution with ρ = 3.1) with 0.28% of nodes seeded. In this figure, loc
and scale are the parameters of the log-Weibull distribution and fracsigma
corresponds to the θ in subsection 3.2.
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Figure 9: The posterior estimation of the parameters of the log-Normal
model for the network with subtype B (sampled from a Waring distribution
with ρ = 3.1) with 0.28% of nodes seeded. In this figure, mu and sigma seed
are the parameters of the log-Normal model and sigma seed corresponds to
the transmission noise parameter in subsection 3.2.
5 Conclusion and Discussion
We present a new protocol that enables researchers to fit set-point viral
load models in their local context, and diagnose the model parameter’s
uncertainty. Such parameter estimates are essential to enable subsequent
modelling analyses, crucial to improve prevention policies.
For future work, we acknowledge that instead of using pairwise genetic
distances, the inference of the transmission network could be improved by
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using viral distances inferred from a phylogenetic tree (i.e., patristic dis-
tances) [15].
Currently we infer the parameters of the degree distribution as an ex-
ternal step using maximum likelihood estimation. In the future, we will
investigate how the inference of the degree distribution can be integrated in
the ABC process.
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